TerminatedNot Applicable

Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy

Stopped: Recruiting of the whole study population not possible.

Finland6 participantsStarted 2013-05-01

Plain-language summary

The study is designed to investigate the efficacy of renal nerve denervation in treating drug-resistant hypertension in patients with end stage renal disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with end stage renal disease and drug-resistant blood pressure. Exclusion Criteria: * pregnancy * secondary hypertension * unstable coronary artery disease

What they're measuring

Comparison of blood pressures before and after intervention

Timeframe: 2 years

Trial details

NCT IDNCT01881035

SponsorTurku University Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2016-12-31

View on ClinicalTrials.gov More Hypertension Secondary to Renal Disease trials